Inovio Pharmaceuticals Inc vs MakeMyTrip Ltd — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $90.50M), while MakeMyTrip Ltd trades at $52.67 (market cap $5.36B). The key difference: MakeMyTrip Ltd is far larger — about 59.2× Inovio Pharmaceuticals Inc's market cap, and MakeMyTrip Ltd is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | MMYT | |
|---|---|---|
Market Cap | $90.50M | $5.36B |
Sector | Health | Technology |
52-Week High | $2.87 | $103.21 |
52-Week Low | $1.05 | $36.30 |
Enterprise Value | $61.51M | $6.00B |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →